Use of rituximab in the of immunoinflammatory rheumatic diseases combined with Graves' disease (autoimmune polyglandular syndrome in adults): case report and literature review
Rituximab (RTM) is a chimeric (murine and human) monoclonal antibody against B-lymphocytes (CD20). RTM is widely used in hematology for lymphoproliferative diseases and in rheumatology for rheumatoid arthritis, Sjögren's disease, some types of vasculitis and systemic connective tissue diseases....
Saved in:
Main Authors: | T. S. Panevin, E. G. Zotkin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2024-10-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/1646 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rituximab in the treatment of Graves’ disease and endocrine ophthalmopathy. Opportunities and limitations
by: T. S. Panevin, et al.
Published: (2023-10-01) -
Evaluation of the short-term efficacy and safety of biological agents in different rheumatic diseases: a multidisciplinary therapeutic hospital"s experience
by: N A Mukhin, et al.
Published: (2013-04-01) -
USE OF RITUXIMAB IN AUTOIMMUNE DISEASES: NEW ASPECTS
by: Dmitry Evgenyevich Karateyev
Published: (2010-09-01) -
Pro-inflammatory activation of monocytes in patients with immunoinflammatory rheumatic diseases
by: A. I. Bogatyreva, et al.
Published: (2024-01-01) -
Experience in Rituximab Administration in Children with Systemic Lupus Erythematosus: a Retrospective Study of the Case Series
by: Mikhail M. Kostik, et al.
Published: (2016-08-01)